Verastem (VSTM) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.35
- EPS estimate
- −$0.43
- EPS surprise
- +18.70%
- Revenue surprise
- +75.17%
- Revenue
- $40.1M
- Revenue estimate
- $22.9M
- Reported
- Aug 6, 2026
Verastem reported Q2 2026 results on August 6, 2026. It posted a loss of $0.35 per share, narrower than the $0.43 loss expected, an 18.70% beat. Revenue was $40.1 million against a $22.9 million estimate. A year earlier, in Q2 2025, the loss was $0.39 per share on revenue of $2.1 million.
Every one of the 20 quarters in the table was a loss, but the annual loss per share has narrowed each year: $4.56 in 2022, $4.10 in 2023, $3.50 in 2024 and $3.09 in 2025. The first half of 2026 adds up to $0.72. Revenue figures are missing for many earlier quarters. Since Q2 2025, revenue has been reported every quarter and has risen each time, from $2.1 million to $11.2 million, $17.5 million, $18.7 million and now $40.1 million, the highest in the table and more than double Q1 2026. Over the 20 quarters shown, Verastem beat the EPS estimate 11 times, including each of the last three.
Q3 results have come out between November 3 and November 8 in each of the past five years. That points to early November 2026 for the next report. It will show whether revenue holds near the Q2 level.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.43 | −$0.35 | +18.70% | $40.1M | SEC |
| Q1 2026 | May 7, 2026 | −$0.47 | −$0.37 | +20.43% | $18.7M | SEC |
| Q4 2025 | Mar 4, 2026 | −$0.52 | −$0.39 | +25.36% | $17.5M | SEC |
| Q3 2025 | Nov 4, 2025 | −$0.62 | −$1.35 | −118.91% | $11.2M | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.73 | −$0.39 | +46.41% | $2.1M | SEC |
| Q1 2025 | May 13, 2025 | −$0.70 | −$0.96 | −37.14% | $0.00 | SEC |
| Q4 2024 | Mar 20, 2025 | −$0.83 | −$1.33 | −60.47% | $0.00 | SEC |
| Q3 2024 | Nov 6, 2024 | −$0.74 | −$0.60 | +18.68% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.96 | −$0.31 | +67.79% | $10.0M | SEC |
| Q1 2024 | May 9, 2024 | −$1.03 | −$1.26 | −22.16% | $0.00 | SEC |
| Q4 2023 | Mar 14, 2024 | −$0.61 | −$1.02 | −66.83% | $0.00 | SEC |
| Q3 2023 | Nov 8, 2023 | −$0.84 | −$0.75 | +11.02% | $0.00 | SEC |
| Q2 2023 | Aug 8, 2023 | −$1.04 | −$1.37 | −31.31% | $0.00 | SEC |
| Q1 2023 | May 9, 2023 | −$1.00 | −$0.96 | +4.00% | $0.00 | SEC |
| Q4 2022 | Mar 14, 2023 | −$1.17 | −$0.96 | +17.62% | $0.00 | SEC |
| Q3 2022 | Nov 3, 2022 | −$1.46 | −$1.08 | +26.03% | $0.00 | — |
| Q2 2022 | Aug 8, 2022 | −$1.32 | −$1.44 | −9.09% | $0.00 | SEC |
| Q1 2022 | May 9, 2022 | −$0.98 | −$1.08 | −9.76% | $2.6M | — |
| Q4 2021 | Mar 28, 2022 | −$1.20 | −$1.08 | +10.00% | $545,000.00 | SEC |
| Q3 2021 | Nov 4, 2021 | −$1.01 | −$1.56 | −53.85% | $2,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Verastem (VSTM) last report earnings?
Verastem last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did VSTM beat earnings estimates?
Yes. Verastem reported EPS of −$0.35 for Q2 2026 against a −$0.43 estimate — a 18.70% beat.
How much revenue did VSTM report last quarter?
Verastem reported $40.1M in revenue for Q2 2026, against a consensus estimate of $22.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.